Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.69B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.36B |
| 3 |
Broadcom
AVGO
|
+$1.16B |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.07B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.99B |
| 2 |
Altria Group
MO
|
+$1.25B |
| 3 |
Carvana
CVNA
|
+$860M |
| 4 |
Danaher
DHR
|
+$829M |
| 5 |
RTX Corp
RTX
|
+$759M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Financials | 10.37% |
| 3 | Healthcare | 9.35% |
| 4 | Consumer Discretionary | 8.71% |
| 5 | Communication Services | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
Espey Mfg & Electronics Corp
ESP
$183M
| $179K | ﹤0.01% |
8,402
+5,877
| +233% | +$134K |
|
5577
Drilling Tools International
DTI
$79.8M
| $178K | ﹤0.01% |
31,706
+28,459
| +876% | +$153K |
|
5578
First Capital
FCAP
$217M
| $178K | ﹤0.01% |
5,928
+1,178
| +25% | +$34.2K |
|
|
ORGN
5579
DELISTED
Origin Materials
ORGN
| $176K | ﹤0.01% |
6,523
-1,566
| -19% | -$41.8K |
|
5580
Gossamer Bio
GOSS
$88.7M
| $175K | ﹤0.01% |
194,664
-4,140,436
| -96% | -$3.1M |
|
|
CANF
5581
Can-Fite BioPharma American Depositary Shares
CANF
$6.83M
| $175K | ﹤0.01% |
3,390
+600
| +22% | +$28.4K |
|
5582
Genelux
GNLX
$126M
| $174K | ﹤0.01% |
89,191
+29,853
| +50% | +$101K |
|
5583
Karyopharm Therapeutics
KPTI
$44.4M
| $174K | ﹤0.01% |
13,334
-6,318
| -32% | -$105K |
|
5584
Global X MSCI Norway ETF
NORW
$87.7M
| $173K | ﹤0.01% |
6,738
-1
| -0% | -$26 |
|
|
GAU
5585
Galiano Gold
GAU
$470M
| $172K | ﹤0.01% |
100,264
+80,194
| +400% | +$131K |
|
5586
Skye Bioscience
SKYE
$20.2M
| $172K | ﹤0.01% |
+21,472
| New | +$255K |
|
|
MURA
5587
DELISTED
Mural Oncology
MURA
| $172K | ﹤0.01% |
54,758
-23,995
| -30% | -$88.4K |
|
5588
TMC The Metals Company
TMC
$1.71B
| $171K | ﹤0.01% |
126,437
+2,955
| +2% | +$4.53K |
|
5589
Vor Biopharma
VOR
$1.21B
| $169K | ﹤0.01% |
8,465
+2,130
| +34% | +$68.9K |
|
5590
C&F Financial
CFFI
$273M
| $168K | ﹤0.01% |
3,495
-2,735
| -44% | -$119K |
|
5591
Compass Therapeutics
CMPX
$357M
| $168K | ﹤0.01% |
167,916
+3,685
| +2% | +$5.38K |
|
5592
Travelzoo
TZOO
$77.1M
| $167K | ﹤0.01% |
21,998
-7,967
| -27% | -$67.8K |
|
5593
Arrow Dow Jones Global Yield ETF
GYLD
$37.5M
| $165K | ﹤0.01% |
12,661
-128
| -1% | -$1.69K |
|
|
CIK
5594
Credit Suisse Asset Management Income Fund
CIK
$133M
| $165K | ﹤0.01% |
55,462
+26,778
| +93% | +$78.5K |
|
5595
Research Frontiers
REFR
$16.3M
| $164K | ﹤0.01% |
89,357
| – | – |
|
5596
Vista Gold
VGZ
$270M
| $164K | ﹤0.01% |
353,133
-5,101
| -1% | -$2.65K |
|
5597
Fidelity Fundamental Large Cap Growth ETF
FFLG
$620M
| $164K | ﹤0.01% |
6,927
| – | – |
|
5598
Mammoth Energy Services
TUSK
$137M
| $164K | ﹤0.01% |
49,923
-3,030
| -6% | -$10.4K |
|
5599
Spruce Power Holding Corp
SPRU
$43.2M
| $164K | ﹤0.01% |
44,841
-7,082
| -14% | -$26.2K |
|
|
DNMR
5600
DELISTED
Danimer Scientific, Inc.
DNMR
| $163K | ﹤0.01% |
6,766
+682
| +11% | +$21.2K |
|
Similar funds
Morgan Stanley's Q2 2024 Portfolio in Review
As of Q2 2024, Morgan Stanley held 8,106 positions worth $1.29T, up 3.7% from $1.25T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2024 filing shows 292 new, 3,358 increased, 3,239 reduced and 253 closed positions. Its largest new stake was iShares Bitcoin Trust: 5,500,627 shares worth $188M. The largest sale was Invesco QQQ Trust, an estimated $2.99B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2024 buy was iShares Bitcoin Trust: 5,500,627 shares worth $188M.
- Morgan Stanley added most to Apple in Q2 2024, an estimated $1.69B increase.
- Morgan Stanley's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $2.99B.
- Morgan Stanley fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $664M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.29T portfolio in Q2 2024.
- Morgan Stanley opened 292 new positions and closed 253 in Q2 2024.
- Morgan Stanley's portfolio value rose 3.7% quarter-over-quarter to $1.29T.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.